Literature DB >> 10366463

MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.

B Davidson1, I Goldberg, J Kopolovic, L Lerner-Geva, W H Gotlieb, G Ben-Baruch, R Reich.   

Abstract

OBJECTIVE: The spread of malignant neoplasms is closely associated with matrix and basement membrane degradation, mediated by various classes of proteolytic enzymes. Matrix metalloproteinases (MMP) appear to have a key role in the sequence of events that lead to local invasion and metastasis. The present study evaluated the role of matrix metalloproteinase-2 (MMP-2), tissue inhibitor of metalloproteinases-2 (TIMP-2), and membrane-type metalloproteinase (MT1-MMP) in cervical neoplasia.
METHODS: We have analyzed 49 uterine cervical squamous cell carcinomas, 10 cases of high-grade cervical intraepithelial neoplasia (CIN II-III), and 10 control cervices for the presence of MMP-2, TIMP-2, and MT1-MMP using in situ hybridization. MMP-2 protein expression was evaluated using immunohistochemistry. Results were analyzed for possible correlation with disease outcome.
RESULTS: MMP-2, TIMP-2, and MT1-MMP mRNA were localized to both stromal and tumor cells. However, an intense signal for MMP-2 was detected almost exclusively in tumor cells and was uniformly absent from CIN lesions and control cervices. Conversely, intense signals for TIMP-2 and MT1-MMP were detected in both stromal and tumor cells of invasive carcinomas, more often for the former. As with MMP-2, they were absent from CIN lesions. MMP-2 protein expression was enhanced in tumor cells compared to CIN cases and controls, significantly compared to the latter (P = 0.01). The presence of both MMP-2 and TIMP-2 mRNA in tumor cells correlated with advanced stage (P = 0.003 for MMP-2, P = 0.002 for TIMP-2) and with poor survival (P = 0.003 for MMP-2, P = 0.002 for TIMP-2) in univariate analysis. In addition, their presence in tumor cells intercorrelated (P = 0.002). In multivariate survival analysis, MMP-2 presence retained its association with survival (P = 0.004), in addition to patient age (P = 0.027) and advanced stage (P = 0. 0002).
CONCLUSIONS: Both MMP-2 and TIMP-2 have a key role in extracellular matrix invasion in cervical carcinoma, largely through their elaboration by tumor cells. The presence of mRNA for both proteins is interrelated and is associated with poor survival. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366463     DOI: 10.1006/gyno.1999.5381

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  21 in total

1.  Nanoparticle self-assembly gated by logical proteolytic triggers.

Authors:  Geoffrey von Maltzahn; Todd J Harris; Ji-Ho Park; Dal-Hee Min; Alexander J Schmidt; Michael J Sailor; Sangeeta N Bhatia
Journal:  J Am Chem Soc       Date:  2007-04-21       Impact factor: 15.419

2.  Protease-triggered unveiling of bioactive nanoparticles.

Authors:  Todd J Harris; Geoffrey von Maltzahn; Matthew E Lord; Ji-Ho Park; Amit Agrawal; Dal-Hee Min; Michael J Sailor; Sangeeta N Bhatia
Journal:  Small       Date:  2008-09       Impact factor: 13.281

3.  Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix.

Authors:  S Asha Nair; D Karunagaran; M B Nair; P R Sudhakaran
Journal:  J Cancer Res Clin Oncol       Date:  2003-02-19       Impact factor: 4.553

4.  Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma.

Authors:  Mumtaz V Rojiani; Janeen Alidina; Nicole Esposito; Amyn M Rojiani
Journal:  Int J Clin Exp Pathol       Date:  2010-10-16

5.  Expression of the TIMP2 gene is not regulated by promoter hypermethylation in the Caski cell line.

Authors:  Gaurav Parashar; Neena Capalash
Journal:  Oncol Lett       Date:  2012-02-13       Impact factor: 2.967

6.  A fluorescent orthotopic model of metastatic cervical carcinoma.

Authors:  Rob A Cairns; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  Expression of matrix metalloproteinase-2 and 9 in cervical intraepithelial neoplasia and cervical carcinoma among different age groups of premenopausal and postmenopausal women.

Authors:  Arnab Ghosh; Anuradha Moirangthem; Rabindranath Dalui; TapanKumar Ghosh; Arghya Bandyopadhyay; Anindya Dasgupta; Uma Banerjee; Narayan Jana; Anupam Basu
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-08       Impact factor: 4.553

Review 8.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

9.  Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma.

Authors:  Lu-Lu Zhai; Chong-Yang Cai; Yang Wu; Zhi-Gang Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 10.  Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.

Authors:  Yongzhuo Huang; Yifan Jiang; Huiyuan Wang; Jianxin Wang; Meong Cheol Shin; Youngro Byun; Huining He; Yanqin Liang; Victor C Yang
Journal:  Adv Drug Deliv Rev       Date:  2013-01-28       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.